Yes, tramadol lowers the seizure threshold, and it does so through multiple mechanisms that set it apart from other opioid painkillers. Seizures have been reported at recommended doses, not just in overdose situations. The risk climbs significantly with higher doses, certain drug combinations, and specific medical histories.
How Tramadol Triggers Seizures
Most opioids don’t carry meaningful seizure risk. Tramadol does because it isn’t just an opioid. It also blocks the reabsorption of serotonin and norepinephrine in the brain, causing these chemicals to build up. Excess serotonin and norepinephrine increase the electrical excitability of neurons, which can push brain activity past the point where a seizure fires.
There’s a second mechanism at work. When your body breaks down tramadol, it produces an active byproduct called M1. This metabolite interferes with a key inhibitory receptor in the brain (GABA-A) that normally acts like a brake on neural firing. When that brake is weakened, especially at higher doses, the brain becomes more prone to uncontrolled electrical activity. Together, the serotonin surge and the GABA disruption create a dual pathway to seizures that other painkillers simply don’t have.
How Often Seizures Occur
At prescribed doses, seizures are uncommon but not rare. In a study of more than 9,000 patients taking tramadol in a managed care setting, fewer than 1% experienced a seizure after their first prescription. That baseline risk increased 2- to 6-fold when patients had certain medical conditions or were taking other medications at the same time.
In overdose, the numbers jump dramatically. A study of 401 patients hospitalized for tramadol overdose found that 30% experienced seizures. Most tramadol-related seizures happen quickly: the median time between ingestion and seizure onset is about 2 hours, and roughly 85% of seizures occur within the first 6 hours.
Seizures from tramadol are typically generalized tonic-clonic, meaning they involve the whole body with muscle stiffening and rhythmic jerking. They can occur even in people with no prior history of epilepsy, no structural brain abnormalities, and no metabolic problems like low blood sugar or low calcium.
Drug Combinations That Raise the Risk
The most dangerous aspect of tramadol’s seizure risk may be how it interacts with other common medications. The FDA label specifically warns that seizure risk increases when tramadol is combined with any of the following:
- SSRIs and SNRIs: Antidepressants like sertraline, fluoxetine, and venlafaxine. These boost serotonin on their own, and adding tramadol can push serotonin levels into a dangerous range. SSRIs are classified as a “major” interaction with tramadol.
- Tricyclic antidepressants: Older antidepressants like amitriptyline and nortriptyline also enhance tramadol’s seizure-promoting effects.
- Other opioids: Combining tramadol with additional opioid medications compounds the risk.
- MAOIs: A class of antidepressants that should generally not be combined with tramadol at all.
- Antipsychotic medications: These can independently lower seizure threshold and compound tramadol’s effects.
The antidepressant connection is particularly important because so many people take both medications simultaneously. When researchers examined 83 cases of tramadol-associated seizures, nearly half involved other prescribed drugs, and more than 50% of those co-prescribed medications were antidepressants. Some antidepressants (particularly certain SSRIs) also inhibit the liver enzyme CYP2D6, which changes how tramadol is metabolized. This can further amplify serotonin and norepinephrine levels, compounding the seizure risk.
Who Faces the Highest Risk
The FDA identifies several groups at elevated risk for tramadol-related seizures: people with epilepsy, those with a history of seizures from any cause, and individuals with head trauma, metabolic disorders, or a history of alcohol or drug withdrawal. Central nervous system infections also increase susceptibility.
Genetics play a role too. Some people are “ultra-rapid metabolizers” of tramadol due to variations in the CYP2D6 gene. Their bodies convert tramadol to its active metabolite faster and in greater quantities, which can intensify both the painkilling effects and the seizure risk. The FDA has flagged this as a particular concern in children, where life-threatening respiratory depression and death have occurred in ultra-rapid metabolizers.
That said, tramadol-induced seizures are not limited to high-risk groups. Studies have documented seizures in patients with no epilepsy history, no brain abnormalities, and normal metabolic lab results. The drug can lower the seizure threshold in otherwise healthy individuals.
Seizures During Withdrawal
Seizures from tramadol don’t only happen while you’re taking it. Case reports describe generalized tonic-clonic seizures occurring during dose tapering and withdrawal periods. One documented case involved a 22-year-old woman who experienced seizures both during active tramadol use (at very high doses of 1,900 to 2,100 mg) and again when her dose was being reduced.
This dual risk window, during both intoxication and withdrawal, is something tramadol shares with alcohol and benzodiazepines rather than with typical opioids. It means that stopping tramadol abruptly after prolonged use carries its own seizure risk, which is why gradual tapering under medical supervision is the standard approach.
The Naloxone Controversy
In a standard opioid overdose, naloxone is the go-to rescue medication. With tramadol, the picture is more complicated. The FDA label for tramadol-containing products notes that naloxone administration during overdose “may increase the risk of seizure.” This is because naloxone reverses tramadol’s opioid effects (which have some protective, anti-seizure properties) while leaving the serotonin and norepinephrine buildup untouched.
Research on this question has produced mixed results. One study of tramadol poisoning patients found that seizure incidence was lower in those who received naloxone (5.1%) compared to those who didn’t (14.1%). But when researchers controlled for other variables, the statistical analysis didn’t confirm a clear protective effect. Animal studies have shown naloxone both reducing and increasing seizure activity depending on the context. The bottom line is that naloxone remains the appropriate emergency response for opioid overdose symptoms like respiratory depression, but its relationship with tramadol-specific seizures is genuinely uncertain.
Practical Takeaways for Tramadol Users
If you take tramadol, the seizure risk is real but manageable with awareness. Staying within prescribed doses is the most important factor, since risk rises sharply above the recommended range. Be particularly cautious if you also take an antidepressant, especially an SSRI or SNRI, as this combination is the most commonly identified trigger for tramadol seizures.
Don’t stop tramadol abruptly after taking it regularly for more than a few weeks. Alcohol use alongside tramadol compounds the seizure risk beyond what either substance carries alone. And if you’ve ever had a seizure for any reason, tramadol is generally considered a poor choice for pain management. Alternative painkillers that don’t affect serotonin or GABA systems are available and worth discussing with whoever manages your prescriptions.